Literature DB >> 26181894

Pneumococcal Meningitis Vaccine Breakthroughs and Failures After Routine 7-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Children in France.

Cécile Godot1, Corinne Levy, Emmanuelle Varon, Capucine Picard, Fouad Madhi, Robert Cohen.   

Abstract

We collected cases of pneumococcal meningitis vaccine breakthrough (VBT) and vaccine failure (VF) from 2003 to 2013 after the implementation of pneumococcal conjugate vaccines (PCVs) in France. VBT accounted for 3.2% of the cases (PCV7 era: 24 of 943, PCV13 era: 15 of 290) and VF 0.6% (PCV7 era: 6 of 943, PCV13 era: 2 of 290). VBT and VF are rare and occur in most cases in children younger than 2 years. The serotype 19F was the most frequent cause even after the introduction of PCV13.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26181894     DOI: 10.1097/INF.0000000000000818

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

Review 1.  The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014.

Authors:  Robert Cohen; Sandra Biscardi; Corinne Levy
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

2.  Invasive pneumococcal disease: From a tertiary care hospital in the post-vaccine era.

Authors:  Sevgen Tanır Basaranoglu; Eda Karadag Oncel; Kubra Aykac; Yasemin Ozsurekci; Ali Bülent Cengiz; Ates Kara; Mehmet Ceyhan
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

3.  Streptococcus pneumoniae serotype 19A meningitis in well-vaccinated immunocompetent 13-month-old child: a case of PCV13 failure.

Authors:  Simon Kayemba-Kay's; Abdul Monem Badran; Cécile Lagneaux; Tamas Kovacs; Anne Heron
Journal:  Clin Case Rep       Date:  2016-09-22

4.  Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis.

Authors:  Anna Alari; Hélène Chaussade; Matthieu Domenech De Cellès; Lénaig Le Fouler; Emmanuelle Varon; Lulla Opatowski; Didier Guillemot; Laurence Watier
Journal:  BMC Med       Date:  2016-12-21       Impact factor: 8.775

5.  Genome-wide analysis of Streptococcus pneumoniae serogroup 19 in the decade after the introduction of pneumococcal conjugate vaccines in Australia.

Authors:  Rebecca J Rockett; Shahin Oftadeh; Nathan L Bachmann; Verlaine J Timms; Fanrong Kong; Gwendolyn L Gilbert; Vitali Sintchenko
Journal:  Sci Rep       Date:  2018-11-16       Impact factor: 4.379

6.  [Meningitis caused by Streptococcus pneumoniae serotype 7a in an infant vaccinated with two doses of 13-valent pneumococcal conjugate vaccine: a case study].

Authors:  Kaoutar Ouazzani Touhami; Hind El Bayed Sakkali; Fakhreddine Maaloum; Idrissa Diawara; Makine Ouazzani Touhami; Mohamed Bezzari; Khalid Zerouali; Houria Belabbes
Journal:  Pan Afr Med J       Date:  2019-04-26

7.  Outpacing the pneumococcus: Antibody dynamics in the first few days following pneumococcal capsular antigen stimulation.

Authors:  Sheila Z Kimaro Mlacha; Anne Warira; Hellen Gatakaa; David Goldblatt; J Anthony G Scott
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

8.  Serotype distribution of Streptococcus pneumonia in children with invasive disease in Turkey: 2015-2018.

Authors:  Mehmet Ceyhan; Kubra Aykac; Nezahat Gurler; Yasemin Ozsurekci; Lütfiye Öksüz; Özlem Altay Akısoglu; Fatma Nur Öz; Melike Emiroglu; Hatice TurkDagi; Akgün Yaman; Güner Söyletir; Candan Öztürk; Nezahat Akpolat; Cüneyt Özakin; Faruk Aydın; Şöhret Aydemir; Abdurrahman Kiremitci; Meral Gültekin; Yıldız Camcıoglu; Yasemin Zer; Hüseyin Güdücüoğlu; Zeynep Gülay; Asuman Birinci; Cigdem Arabaci; Adem Karbuz; Ilker Devrim; Yelda Sorguc; Betil Özhak Baysan; Eda Karadag Oncel; Nisel Yilmaz; Yasemin Ay Altintop
Journal:  Hum Vaccin Immunother       Date:  2020-06-12       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.